Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Lab Chip ; 24(15): 3718-3727, 2024 Jul 23.
Article in English | MEDLINE | ID: mdl-38953554

ABSTRACT

The in vitro recapitulation of tumor microenvironment is of great interest to preclinical screening of drugs. Compared with culture of cell lines, tumor organ slices can better preserve the complex tumor architecture and phenotypic activity of native cells, but are limited by their exposure to fluid shear and gradual degradation under perfusion culture. Here, we established a decellularized liver matrix (DLM)-GelMA "sandwich" structure and a perfusion-based microfluidic platform to support long-term culture of tumor slices with excellent structural integrity and cell viability over 7 days. The DLM-GelMA was able to secrete cytokines and growth factors while providing shear protection to the tumor slice via the sandwich structure, leading to the preservation of the tumor microenvironment where immune cells (CD3, CD8, CD68), tumor-associated fibroblasts (α-SMA), and extracellular matrix components (collagen I, fibronectin) were well maintained. Furthermore, this chip presented anti-tumor efficacy at cisplatin (20 µM) on tumor patients, demonstrating our platform's efficacy to design patient-specific treatment regimens. Taken together, the successful development of this DLM-GelMA sandwich structure on the chip could faithfully reflect the tumor microenvironment and immune response, accelerating the screening process of drug molecules and providing insights for practical medicine.


Subject(s)
Lab-On-A-Chip Devices , Tumor Microenvironment , Humans , Tumor Microenvironment/drug effects , Antineoplastic Agents/pharmacology , Antineoplastic Agents/chemistry , Cisplatin/pharmacology , Cisplatin/chemistry , Drug Screening Assays, Antitumor/instrumentation , Animals , Liver/metabolism , Liver/pathology , Cell Line, Tumor , Extracellular Matrix/metabolism
2.
Chem Sci ; 15(9): 3357-3364, 2024 Feb 28.
Article in English | MEDLINE | ID: mdl-38425523

ABSTRACT

Four-electron aqueous zinc-iodine batteries (4eZIBs) leveraging the I-/I0/I+ redox couple have garnered attention for their potential high voltage, capacity, and energy density. However, the electrophilic I+ species is highly susceptible to hydrolysis due to the nucleophilic attack by water. Previous endeavors to develop 4eZIBs primarily relied on highly concentrated aqueous electrolytes to mitigate the hydrolysis issue, nonetheless, it introduced challenges associated with dissolution, high electrolyte viscosity, and sluggish electrode kinetics. In this work, we present a novel complexation strategy that capitalizes on quaternary ammonium salts to form solidified compounds with I+ species, rendering them impervious to solubilization and hydrolysis in aqueous environments. The robust interaction in this complexation chemistry facilitates a highly reversible I-/I0/I+ redox process, significantly improving reaction kinetics within a conventional ZnSO4 aqueous electrolyte. The proposed 4eZIB exhibits a superior rate capability and an extended lifespan of up to 2000 cycles. This complexation chemistry offers a promising pathway for the development of advanced 4eZIBs.

SELECTION OF CITATIONS
SEARCH DETAIL